Brief: Clovis Oncology Reports Quarterly Loss Per Share Of $0.50
23/02/2022 14:17
Feb 23 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY INC - QTRLY LOSS PER SHARE $0.50
* CLOVIS ONCOLOGY INC - QTRLY PRODUCT REVENUE $36 MILLION
VERSUS
$43.3 MILLION
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber